Array BioPharma to Present at the 26th Annual Canaccord Adams Summer Seminar

Aug 01, 2006, 01:00 ET from Array BioPharma Inc.

    BOULDER, Colo., Aug. 1 /PRNewswire-FirstCall/ -- Array BioPharma Inc.
 (Nasdaq:   ARRY) today announced that its Chief Executive Officer, Robert E.
 Conway, will speak at the 26th Annual Canaccord Adams Summer Seminar on
 August 9 in Boston. The public is welcome to participate in the conference
 through an audio webcast on the Array BioPharma website.
     Event:          26th Annual Canaccord Adams Summer Seminar
     Presenter:      Robert E. Conway, Chief Executive Officer, Array BioPharma
     Date:           Wednesday, August 9, 2006
     Time:           2:30 pm Eastern Time
     Location:       Boston Marriott Long Wharf
     Audio Webcast:
     About Array BioPharma:
     Array BioPharma Inc. is a biopharmaceutical company focused on the
 discovery, development and commercialization of targeted small molecule
 drugs to treat life threatening and debilitating diseases. Our proprietary
 drug development pipeline is focused on the treatment of cancer and
 inflammatory disease and includes clinical candidates that are designed to
 regulate therapeutically important targets. In addition, leading
 pharmaceutical and biotechnology companies collaborate with Array to
 discover and develop drug candidates across a broad range of therapeutic
 areas. For more information on Array, please go to

SOURCE Array BioPharma Inc.